AstraZeneca Pharma India Limited logo

AstraZeneca Pharma India Limited

NSE:ASTRAZEN.NS

Overview | Financials
Company Name AstraZeneca Pharma India Limited
Symbol ASTRAZEN.NS
Currency INR
Price 7,306.8
Market Cap 182,670,000,000
Dividend Yield 0.29%
52-week-range 4,510 - 8,139
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Sanjeev Kumar Panchal
Website https://www.astrazeneca.in

An error occurred while fetching data.

About AstraZeneca Pharma India Limited

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, distributes, and markets pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease and diabetes medicines under the Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, and QTERN brands; Respiratory medicines under the Symbicort and FASENRA

Related Stocks

Poly Medicure Limited logo

Poly Medicure Limited

POLYMED.NS

2,781 INR

Jubilant Pharmova Limited logo

Jubilant Pharmova Limited

JUBLPHARMA.NS

1,239 INR

Granules India Limited logo

Granules India Limited

GRANULES.NS

584.5 INR

Procter & Gamble Health Limited logo

Procter & Gamble Health Limited

PGHL.NS

5,570.2 INR

Jubilant Ingrevia Limited logo

Jubilant Ingrevia Limited

JUBLINGREA.NS

712.05 INR

Sun Pharma Advanced Research Company Limited logo

Sun Pharma Advanced Research Company Limited

SPARC.NS

207.44 INR

Caplin Point Laboratories Limited logo

Caplin Point Laboratories Limited

CAPLIPOINT.NS

2,011.8 INR

Metropolis Healthcare Limited logo

Metropolis Healthcare Limited

METROPOLIS.NS

2,115.45 INR

Glenmark Life Sciences Limited logo

Glenmark Life Sciences Limited

GLS.NS

1,096.1 INR

Hikal Limited logo

Hikal Limited

HIKAL.NS

386.95 INR

Financials

Numbers are in millions USD

Numbers are in millions USD